fashion -WSS

fashion

author：leisure time 2025-09-03 03:36:20 - browse：71

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: Bayer study halts, Carmot to IPO, and more

WSS

3 hurdles to bringing medical devices to the U.S. market

New guidelines on severe brain injury complicate already difficult decisions

Why drug prescriptions should include diagnoses

In key trial, Verve's treatment lowers cholesterol levels in patients

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Gene therapy has helped boys walk. Can scientists keep it that way?

Wikipedia

fashion

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Does good food count as health care? Study aims to find out

Duchenne breakthrough therapy leaves behind pioneering families

Congress must reauthorize a committee to support older Americans

Heart attack and stroke risk calculators need revising

The science behind Janet Jackson's pregnancy at 49

DIEP, the 'gold standard' of breast reconstruction, is under threat

Paxlovid study fails to answer questions over benefit for broader groups

Tori Bowie and the unacceptable rates of Black maternal death

CRISPR pioneers react to Casgevy, first gene

Wikipedia

The battle over the Brookhaven Landfill on Long Island

Why medical students are struggling with mental health

Surge of respiratory disease in China has likely explanation

WATCH: Why do fingernails fall off when they're damaged?

The story of mRNA: From a loose idea to a tool that may help curb Covid

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

hotspot

leisure time

hotspot

focus